Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$1,500,000.00Target Investment:
$1,500,000.00
Skills
Education
- Uo
- BU
- Uo
Lists including Jon
Work Experience
2023
Principal
2023
2024
Board Member
2024
2024
Board Observer
2024
2020 - 2023
Senior Associate
2022 - 2023
Public (long/short) and private (newco through crossover) investment across medtech, tools, services, AI drug design, diagnostics, and oncology.
Associate
2020 - 2021
Diligence toward investments in CTKB, RXST, TIL, KNTE, Exo, Nodexus, Synthekine, Asher, and New Equilibrium Biosciences.
2021 - 2023
Board Observer
2021 - 2023
Nodexus is a private research tools company launching a microfluidic cell sorter (the NX One) differentiated by lower cost and higher performance relative to existing instruments in its class.
2021 - 2023
Board Observer
2021 - 2023
Exo Imaging is a private AI-enabled medtech company launching a best-in-class handheld point-of-care ultrasound imaging device (Iris) based on novel pMUT semiconductor tech and companion enterprise software (ExoWorks).
2019 - 2019
Venture Creation Fellow
2019 - 2019
Conceived of first-in-class platform technologies which together formed the basis for company-creation proposals. Due diligence included extensive scientific literature research, interviewing dozens of leading experts, and designing proof-of-concept wet lab experiments. Presented newco proposals to CEO and partnership.
2019 - 2019
Intern
2019 - 2019
Supported deal screening and diligence. Surveyed the landscape of a medtech sector of interest to the firm, documented findings in a report, and presented findings to the partnership. Attended VC University training program co-hosted by the University of California, Berkeley and the National Venture Capital Association.
2013 - 2014
Mechanical Engineer
2013 - 2014
Contributed to the development of microfluidics-based point-of-care qPCR diagnostic devices for the Bill and Melinda Gates Foundation and Micronics, passive vaccine storage for Intellectual Ventures Laboratory, and autologous cell therapy production equipment for Sotio.
2010 - 2013
Mechanical Engineer
2010 - 2013
Led hardware R&D efforts toward the production of an assay for the isolation and imaging of rare circulating tumor cells (CTCs – as few as 1 in 50 billion) from whole human blood. Outfitted and oversaw a small machine shop and laser metrology lab. Efforts resulted in 17 patent applications.